InMed Pharmaceuticals Statistics
Total Valuation
INM has a market cap or net worth of $10.34 million. The enterprise value is $9.20 million.
| Market Cap | 10.34M |
| Enterprise Value | 9.20M |
Important Dates
The last earnings date was Tuesday, November 3, 2026, before market open.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INM has 664,410 shares outstanding. The number of shares has increased by 151.03% in one year.
| Current Share Class | 549,374 |
| Shares Outstanding | 664,410 |
| Shares Change (YoY) | +151.03% |
| Shares Change (QoQ) | +16.41% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 73.66% |
| Float | 371,495 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.50
| Current Ratio | 0.50 |
| Quick Ratio | 0.45 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -938.21 |
Financial Efficiency
Return on equity (ROE) is -222.07% and return on invested capital (ROIC) is -113.75%.
| Return on Equity (ROE) | -222.07% |
| Return on Assets (ROA) | -85.56% |
| Return on Invested Capital (ROIC) | -113.75% |
| Return on Capital Employed (ROCE) | 836.99% |
| Weighted Average Cost of Capital (WACC) | 9.72% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.27M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.06% in the last 52 weeks. The beta is 0.99, so INM's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | -10.06% |
| 50-Day Moving Average | 13.95 |
| 200-Day Moving Average | 12.14 |
| Relative Strength Index (RSI) | 53.95 |
| Average Volume (20 Days) | 9,555 |
Short Selling Information
The latest short interest is 6,634, so 1.00% of the outstanding shares have been sold short.
| Short Interest | 6,634 |
| Short Previous Month | 34,080 |
| Short % of Shares Out | 1.00% |
| Short % of Float | 1.79% |
| Short Ratio (days to cover) | 0.11 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.04M |
| Pretax Income | -11.54M |
| Net Income | -13.60M |
| EBITDA | -9.89M |
| EBIT | -10.04M |
| Earnings Per Share (EPS) | -$29.93 |
Balance Sheet
The company has $1.13 million in cash and no debt, with a net cash position of $1.13 million or $1.71 per share.
| Cash & Cash Equivalents | 1.13M |
| Total Debt | n/a |
| Net Cash | 1.13M |
| Net Cash Per Share | $1.71 |
| Equity (Book Value) | -1.20M |
| Book Value Per Share | -2.18 |
| Working Capital | -1.24M |
Cash Flow
| Operating Cash Flow | -7.86M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 152,237 |
| Net Borrowing | n/a |
| Free Cash Flow | -7.86M |
| FCF Per Share | -$11.82 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -151.03% |
| Shareholder Yield | -151.03% |
| Earnings Yield | -192.37% |
| FCF Yield | -75.98% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on November 5, 2026. It was a reverse split with a ratio of 1:10.
| Last Split Date | Nov 5, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |